Table 1.
Asian prostate cancer risk prediction models
Study | Population | Variables | PCa detection rate (%) |
---|---|---|---|
Suzuki et al54 | Japanese | Age, PSA, PV, DRE, % fPSA | 28.9 |
Park et al55 | Korean | Age, PSA, DRE, Prostate TZ volume | 28.6 |
Yoon et al35 | Korean | Age, PSA, DRE, Prostate TZ volume | 28.6 |
Tang et al28 | Chinese | Age, PSA, PV, DRE | 44.8 |
Kuo et al56 | Chinese | Age, PSA, PV, DRE, TRUS echogenicity | 34.4 |
Jeong et al49 | Korean | Age, PSA, PV, TRUS, DRE | 35.6 |
Huang et al57 | Chinese | Age, PSA, PV, DRE, %fPSA, TRUS | 41.5 |
Wu et al58 | Chinese | Age, PSA, PV, DRE, %fPSA, TRUS | 45.3 |
Chen et al21 | Chinese | Age, PSA, PV, DRE, %fPSA, | 36.6 |
PCa-prostate cancer; PSA-prostate-specific antigen; PV- prostate volume; DRE-digital rectal examination; %fPSA-percentage free PSA; TZ-transitional zone; TRUS- transrectal ultrasonogram.